Safety and Feasibility of Transcatheter Aortic Valve Replacement in COVID-19 Patients: A Case Series.
Cardiovasc Revasc Med
; 28S: 68-71, 2021 07.
Article
in English
| MEDLINE | ID: covidwho-1176553
ABSTRACT
In 2020, the coronavirus disease 2019 (COVID-19) pandemic has led to a decrease in interventional treatment for structural heart disease worldwide. In this context, the management of patients with symptomatic severe aortic stenosis (AS) or bioprosthetic valve dysfunction (BVD) represents a clinical challenge, as a delay in aortic valve replacement procedures may increase short-term morbidity and mortality. We report four cases of TAVR performed in patients with Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. All of them were discharged in good clinical conditions and no adverse events were reported at 30 days follow-up. Our experience suggests that in selected patients with mild SARS-CoV-2 infection and symptomatic native AS or BVD, TAVR has a favorable short-term outcome.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Aortic Valve Stenosis
/
Heart Valve Prosthesis
/
Transcatheter Aortic Valve Replacement
/
COVID-19
Type of study:
Case report
/
Cohort study
/
Prognostic study
Limits:
Humans
Language:
English
Journal:
Cardiovasc Revasc Med
Journal subject:
Vascular Diseases
/
Cardiology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS